Skip to main content
Clinical Trials/NCT01616836
NCT01616836
Completed
Phase 3

Optimizing Pain and Rehabilitation After Knee Arthroplasty - Randomized, Blinded Clinical Trial Comparing Continuous Femoral Nerve Block Versus Single Injection Femoral Nerve Block Versus Local Infiltration Analgesia

Sunnybrook Health Sciences Centre2 sites in 1 country100 target enrollmentSeptember 2012

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Total Knee Arthroplasty
Sponsor
Sunnybrook Health Sciences Centre
Enrollment
100
Locations
2
Primary Endpoint
Numeric Rating Scale for Pain
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The aim of this study is to determine the best method of pain control that will help with rehabilitation after total knee arthroplasty (TKA). Currently, the best method for pain control after TKA appears to be continuous femoral nerve block (FNB) where a small tube is placed beside the nerve that provides sensation to a large part of the knee and local anesthetic infused after surgery causing numbness to the surgical site. A single injection method also exists and may provide similar benefits. Both methods require training and can result in side effects such as temporary weakness (while the local anesthetic is still working) that can inhibit rehabilitation. A newer method injecting local anesthetic into the joint after surgery (Local Infiltration Analgesia (LIA)) is becoming common, does not cause weakness and can be done quickly at the end of surgery. It is unknown if the pain control provided by LIA is as good as that of FNB. This study will compare the femoral nerve block, continuous femoral nerve block and LIA technique to determine which provides better pain relief after TKA.

Detailed Description

This will be a prospective, randomized, double blind study. Patients will be randomized using a computer-generated sequence to one of three groups: Group 1: Continuous femoral nerve block group (cFNB) Group 2: Single injection femoral nerve block group (sFNB) Group 3: Local infiltration analgesia group (LIA) Inclusion criteria: Patients between the ages of 18 and 85 having primary tri-compartmental total knee arthroplasty. Exclusion criteria: Allergy, intolerance, or contraindication to any study medication (see below), inability to walk independently prior to TKA, inability to comprehend French or English, use of major tranquilizers, ASA 4 or 5, BMI \> 40, opioid tolerance (opioid consumption \> 30mg oral morphine or equivalent per day), pregnancy

Registry
clinicaltrials.gov
Start Date
September 2012
End Date
December 2014
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dr. Stephen Choi

Staff Anesthesiologist, Associate Professor Department of Anesthesia

Sunnybrook Health Sciences Centre

Eligibility Criteria

Inclusion Criteria

  • Adults undergoing primary, tri-compartmental knee arthroplasty

Exclusion Criteria

  • Allergy, intolerance, or contraindication to any study medication
  • Inability to walk independently prior to TKA
  • Inability to comprehend French or English
  • Use of major tranquilizers
  • ASA 4 or 5
  • BMI \> 40
  • Opioid tolerance (opioid consumption \> 30mg oral morphine or equivalent per day)
  • Pregnancy

Outcomes

Primary Outcomes

Numeric Rating Scale for Pain

Time Frame: 09h00 on postoperative day 2

Pain at this time is the primary impediment to beginning physiotherapy and achieving discharge criteria

Secondary Outcomes

  • Opioid consumption(Cumulative 4 day consumption)
  • Knee range of motion(Measured each postoperative day (4 day maximum) during daily physiotherapy session)
  • Six minute walk test(Measured once at the first postoperative visit with the surgeon, 6 weeks postoperative)
  • WOMAC(Baseline questionnaire given preoperatively, at first postoperative visit (6 weeks), and second postoperative visit (3 months))
  • Complications of femoral nerve block, local infiltration analgesia(From date of randomization until the first postoperative visit at 6 weeks)
  • Inability to ambulate/falls(Participants will be followed for the duration of hospital stay, an expected average of 4 days)
  • LEFS(Baseline questionnaire given preoperatively, at first postoperative visit (6 weeks), and second postoperative visit (3 months))
  • Incidence of motor block(Participants will be followed for the duration of hospital stay, an expected average of 4 days)
  • NRS for pain(The highest NRS will be assessed daily during the patient's physiotherapy session, as well as the highest NRS achieved at 2 weeks, 6 weeks, and 3 months postoperatively)
  • Timed up and go(Measured once on postoperative day 2 during the physiotherapy session)
  • Nausea(Participants will be followed for the duration of hospital stay, an expected average of 4 days)

Study Sites (2)

Loading locations...

Similar Trials